Chadha K C, Munyon W
J Virol. 1975 Jun;15(6):1475-86. doi: 10.1128/JVI.15.6.1475-1486.1975.
Antiserum prepared against herpes simplex virus type 1 (HSV-1)-infected L cells, i.e., lytic antiserum, was shown by an indirect immunofluorescence test to stain 90 percent of HSV-transformed L or HeLa cells. Immunofluorescence in these cells was always most intense in the perinuclear cytoplasmic region. Similar results were obtained with antiserum prepared against HSV-transformed L cells. These data indicate that HSV-transformed cells (both L and HeLa) express HSV-related antigens. Antiserum prepared against HSV-1-transformed L cells, i.e., transformed-cell antiserum, was found to agglutinate purified HSV type 1 virions but failed to neutralize infectivity. This suggests that HSV-1 structural antigens are expressed in HSV-1-transformed L cells. Immunodiffusion studies showed that at least two HSV-related antigens could be demonstrated with antigens from HSV-1-transformed L cells and transformed-cell antiserum. These two antigens were shown to be present in all clonal lines of HSV-1-transformed cells examined, six L cell lines and one HeLa cell line. Therefore, we conclude that transformation of cells by HSV-1, which is known to be associated with acquisition of viral thymidine kinase, must also be associated with the presence of these two antigens. We performed experiments showing that there are species of HSV-related antibody in HSV-transformed cell antiserum that could not be absorbed out with antigens from HSV-infected L cells. Antibodies present in lytic antiserum were completely removed by antigen preparations from cells lytically infected with HSV-1. Also, lytic antiserum failed to block HSV-related staining of transformed L cells in a direct immunofluorescence test. These results are compatible with one of two notions: either (i) certain genes are expressed during transformation that are not expressed during lytic infection, or (ii) these genes are expressed to a much more reduced extent during lytic infection than in transformed cells.
用抗1型单纯疱疹病毒(HSV - 1)感染的L细胞制备的抗血清,即裂解抗血清,通过间接免疫荧光试验显示可对90%的HSV转化的L细胞或HeLa细胞进行染色。这些细胞中的免疫荧光在核周细胞质区域总是最为强烈。用针对HSV转化的L细胞制备的抗血清也得到了类似结果。这些数据表明HSV转化的细胞(L细胞和HeLa细胞)都表达与HSV相关的抗原。用针对HSV - 1转化的L细胞制备的抗血清,即转化细胞抗血清,被发现可凝集纯化的1型单纯疱疹病毒颗粒,但无法中和其感染性。这表明HSV - 1结构抗原在HSV - 1转化的L细胞中表达。免疫扩散研究表明,用HSV - 1转化的L细胞的抗原和转化细胞抗血清可证明至少两种与HSV相关的抗原。在所检测的所有HSV - 1转化细胞的克隆系中,即六个L细胞系和一个HeLa细胞系中,都显示存在这两种抗原。因此,我们得出结论,已知与获得病毒胸苷激酶相关的HSV - 1对细胞的转化,必定也与这两种抗原的存在相关。我们进行的实验表明,HSV转化细胞抗血清中存在一些与HSV相关的抗体,这些抗体不能被HSV感染的L细胞的抗原吸收掉。裂解抗血清中的抗体被来自HSV - 1裂解感染细胞的抗原制剂完全去除。此外,在直接免疫荧光试验中,裂解抗血清未能阻断转化L细胞的HSV相关染色。这些结果与以下两种观点之一相符:要么(i)某些基因在转化过程中表达,而在裂解感染过程中不表达,要么(ii)这些基因在裂解感染过程中的表达程度比在转化细胞中大大降低。